ACCA · Question 32 · Preparation of Single Entity Financial Statements
Section C - Constructed Response 2
BioPharma Innovations is preparing its financial statements for the year ended 31 December 20X5.
Draft figures before adjustments ($'000):
Revenue: 45,000
Cost of Sales: (22,000)
Gross Profit: 23,000
Operating Expenses: (12,000)
Operating Profit: 11,000
Finance Costs: (1,000)
Profit Before Tax: 10,000
Equity and Liabilities at 31 Dec 20X5 (Draft, $'000):
Equity: 30,000
Long-term Loan: 15,000
Adjustments required:
Requirement:
(a) Prepare the revised Statement of Profit or Loss and Other Comprehensive Income for the year ended 31 December 20X5. (10 marks)
(b) Calculate the following ratios for 20X5 based on your revised figures:
i. Operating Profit Margin
ii. Interest Cover
iii. Return on Capital Employed (ROCE) (Use closing capital employed). (6 marks)
(c) Briefly comment on the impact of capitalizing the development costs on the ROCE compared to if they had been fully expensed. (4 marks)
32 questions · hints · full answers · grading